| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/11/2007 | EP1772156A1 Liposome-containing x-ray radiopaque dye and process for producing the same |
| 04/11/2007 | EP1307237B1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 04/11/2007 | EP1175227B1 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 04/11/2007 | EP0741748B1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 04/11/2007 | CN1944437A Tree shape Macro molecule paramagnetic metal complex and synthetic method and use |
| 04/11/2007 | CN1943791A Liver target high molecule magnetic resonance image-forming contrast medium and its synthesizing method and application |
| 04/11/2007 | CN1943565A Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method |
| 04/11/2007 | CN1309586C Nonskid device for wheels of vehicles |
| 04/10/2007 | US7202211 Methods of preventing or treating brain ischemia or brain injury |
| 04/10/2007 | US7201892 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
| 04/10/2007 | US7201890 Parenterally injecting patient with labeled divalent single chain antibody fragment or subfragment; conducting procedure within 48 hours of the injection; scanning the accessed interior locating sites of accretion of labeled antibody |
| 04/10/2007 | CA2377746C N-pyrazole a2a receptor agonists |
| 04/10/2007 | CA2316808C Transgenic rabbit that expresses a functional human lipoprotein (a) |
| 04/10/2007 | CA2311599C Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
| 04/10/2007 | CA2236001C Biologically active eph family ligands |
| 04/10/2007 | CA2222068C Chimeric fatty body-pro-grf analogs with increased biological potency |
| 04/10/2007 | CA2200061C Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 04/10/2007 | CA2190108C Somatostatin binding peptide-metal chelate conjugates |
| 04/05/2007 | WO2007038626A2 Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging |
| 04/05/2007 | WO2007038249A2 Ultrasonic concentration of carrier particles |
| 04/05/2007 | WO2007036682A1 Coated microspheres |
| 04/05/2007 | WO2006108047A3 Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization |
| 04/05/2007 | WO2006099019A3 Methods and composition related to in vivo imaging of gene expression |
| 04/05/2007 | WO2006079119A3 Modulation of th2 lineage commitment by t-bet |
| 04/05/2007 | WO2006073419A3 Lipoprotein nanoplatforms |
| 04/05/2007 | WO2006054904A3 Contrast agents to target extracellular matrix |
| 04/05/2007 | WO2006023658A8 Method of pre-selecting patients for anti-vegf, anti-hif-1 or anti-thioredoxin therapy |
| 04/05/2007 | US20070079390 Animal model for schizophrenia |
| 04/05/2007 | US20070079388 Human hookworm model and method for maintaining human hookworm in a non-human primate |
| 04/05/2007 | US20070078108 Liquid composition for bulging mucous membrane for use in endoscopic surgery comprising a chitosan derivative containing carbohydrate chains |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077206 Characterization of microbial deposition and immune response at the basement membrane and methods relating thereto |
| 04/05/2007 | US20070077205 Use of non-invasive imaging technologies to monitor in vivo gene-expression |
| 04/05/2007 | US20070077204 Olfactory identification tests for cognitive diseases and disorders |
| 04/05/2007 | US20070077203 Surrogate markers |
| 04/05/2007 | US20070077202 Histostain composition for endoscope |
| 04/05/2007 | US20070077201 Stem cell expansion and uses |
| 04/05/2007 | US20070077200 Method and system for controlled maintenance of hypoxia for therapeutic or diagnostic purposes |
| 04/05/2007 | US20070077197 Cancer diagnosis; antitumor agents, radiotherapy |
| 04/05/2007 | US20070076930 System and method for detecting content in-vivo |
| 04/04/2007 | EP1768707A2 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 04/04/2007 | EP1768705A2 Method for detecting alzheimer"s disease and other forms of dementia, and measuring their progression |
| 04/04/2007 | EP1768704A2 Imaging infection with compounds that bind to thymidine kinase |
| 04/04/2007 | EP1768558A1 Lipohilic derivatives of chelate monoamides |
| 04/04/2007 | EP0951292B1 Treating an ischemic disorder and improving stroke outcome |
| 04/04/2007 | CN1942702A Illuminating device |
| 04/04/2007 | CN1942430A 5-aminolevulinic acid phosphate, method for producing the same and use thereof |
| 04/04/2007 | CN1308684C Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/03/2007 | US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy |
| 04/03/2007 | US7198949 Compositions and methods for altering the biodistribution of biological agents |
| 04/03/2007 | US7198777 Optical contrast agents for optically modifying incident radiation |
| 04/03/2007 | US7198776 Metal complex compounds |
| 04/03/2007 | US7198774 Non-invasive localization of a light-emitting conjugate in a mammal |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2259950C Radiometal-binding peptide analogues |
| 04/03/2007 | CA2134082C Bioadhesive microspheres and their use as drug delivery and imaging systems |
| 03/29/2007 | WO2007034757A1 Remedy for amyloid diseases and drug for monitoring the same |
| 03/29/2007 | WO2006105038A3 Methods of altering gene expression and methods of treatment utilizing same |
| 03/29/2007 | WO2006009682A3 Glue compositions for lung volume reduction |
| 03/29/2007 | WO2005094285A3 Percutaneous chemical sensor based on fluorescence resonant energy transfer (fret) |
| 03/29/2007 | US20070074295 Schizophrenia related gene |
| 03/29/2007 | US20070072251 In vivo imaging using peptide derivatives |
| 03/29/2007 | US20070072243 Multiplex screening for lysosomal sotrage disorders (lsds) |
| 03/29/2007 | US20070071685 Gas-filled microvesicle assembly for contrast imaging |
| 03/29/2007 | US20070071683 Ultrasonic concentration of carrier particles |
| 03/29/2007 | US20070071682 Methods for testing vaccine candidates against bacterial infection in rodents |
| 03/29/2007 | US20070071681 Apparatus and method for computer modeling type 1 diabetes |
| 03/29/2007 | US20070071680 Methods and compositions for preparing consumables with optical shifting properties |
| 03/29/2007 | US20070071679 Methylamine risks and treatment of hyperactivity, depression, and alcoholism with epinephrine-N-quinolines |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | CA2622845A1 Imaging agents comprising silicon |
| 03/28/2007 | EP1767223A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/28/2007 | EP1767222A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/28/2007 | EP1767195A2 Stable spray-dried protein formulations |
| 03/28/2007 | EP1767192A2 Cationic lipid compositions targeting angiogenic endothelial cells |
| 03/28/2007 | EP1766390A2 Novel means and methods for the treatment of hearing loss and phantom hearing |
| 03/28/2007 | EP1766309A2 Method and apparatus for accumulating hyperpolarized xenon |
| 03/28/2007 | EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 03/28/2007 | EP1765812A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 03/28/2007 | EP1765455A2 Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
| 03/28/2007 | EP1765292A1 Abuse-deterrent drug formulations |
| 03/28/2007 | EP1765172A2 Intravascular imaging device and uses thereof |
| 03/28/2007 | EP1765163A1 A method of enhancing visualization of atherosclerotic plaque |
| 03/28/2007 | EP1765162A1 Contrast agents for magnetic resonance imaging |
| 03/28/2007 | EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 03/28/2007 | EP1082416B1 Poly(adp-ribose)polymerase gene |
| 03/28/2007 | CN1938050A X-ray contrast formulation comprising a mixture of iodinated monomer and dimer |
| 03/28/2007 | CN1935277A Preparation for the prophylaxis of restenosis |
| 03/28/2007 | CN1935266A Method for establishing mouse breast cancer tumour model for trans hCG beta gene |
| 03/28/2007 | CN1935263A Nano carbon suspension injection |
| 03/28/2007 | CN1935257A Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method |
| 03/28/2007 | CN1307200C Substantially homogeneous bio-affecting material having predetermined ratio of bio-affecting component to cell targeting component, method for making such material and use |
| 03/28/2007 | CN1306916C Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 03/27/2007 | US7196063 Peptides and pharmaceutical compositions comprising same |
| 03/27/2007 | CA2242750C Antibodies with reduced net positive charge |
| 03/22/2007 | WO2007032770A2 Serotonin and catecholamine segment optimization technology |
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007031777A2 Method of determining damage to skin |
| 03/22/2007 | WO2007005283A3 Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| 03/22/2007 | WO2006123936A3 Contrast agents comprising tungsten- containing cores |